REBYOTA™ Prospective Registry

Clinical trial NCT05835219 · COMPLETED

Trial details

NCT number: NCT05835219
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Recurrence of Clostridium Difficile Infection

Start date: 2023-06-19
Primary completion: 2025-08-29
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.